国产精品国产三级区别第一集,亚洲精品国产成人,精品人妻无码一区二区三区,人妻熟妇乱又伦精品视频

咨詢熱線

15000266580

當(dāng)前位置:首頁  >  技術(shù)文章  >  日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

更新時間:2013-07-26      點(diǎn)擊次數(shù):3318

   日本研究人員獲得批準(zhǔn),可以開展利用干細(xì)胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導(dǎo)AMD患者身上取下的皮膚細(xì)胞使其處于一種類似于干細(xì)胞的狀態(tài)后再將其轉(zhuǎn)至患者,以達(dá)到治療效果。

干細(xì)胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細(xì)胞領(lǐng)域的研究獲得諾貝爾獎。

詳細(xì)英文報(bào)道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
亚洲日韩精品无码专区网址 | av无码天堂一区二区三区| 国产舌乚八伦偷品W中| 国产边添边摸边做边爱| 12裸体自慰免费观看网站| 老司机精品视频| 日韩AV无码精品一二三区| 狠狠人妻久久久久久综合蜜桃| 精品国产一区二区三区久久影院 | 国产vpswindows精品| 色综合99久久久无码国产精品 | 久久久久久精品免费看sss| 天天人人爽人人爽人人爽动漫 | 精品国产青草久久久久福利 | 又粗又大又硬毛片免费看| 午夜精品久久久久久99热蜜桃| 色一情一乱一伦一区二区三区日本 | 精品久久久久久久无码人妻热| 亚洲爆乳精品无码一区二区| 色欲AV伊人久久大香线蕉影院| 亚洲AV无码一区二区三区人| 国产午夜精品一区理论片飘花 | av无码久久久久不卡蜜桃| 欧美直播APP| 国产手机精品一区二区| 免费b站在线观看人数在哪儿找| 国产舌乚八伦偷品W中| 亡は夫の上司最美人妻| 无码少妇高潮浪潮AV久久| 精品国产乱码久久久久乱码| 99久久久精品免费观看国产| 国内精品久久久人妻中文字幕| 青青青伊人色综合久久| 国产最新精品SM调教视频| jiapanese50欧美熟妇| 国产色情一区二区视频| 精品国产AV一区二区三区| 韩国漫画漫免费观看免费| 少妇人妻一区二区三区视频| 欧美熟妇另娄久久久久久| 国产在线观看|